Recent Patents on Anti-Cancer Drug Discovery

期刊全称Recent Patents on Anti-Cancer Drug Discovery
期刊缩写RECENT PAT ANTI-CANC
涉及主题生物医学遗传学内科学化学生物化学癌症癌症研究药理学基因有机化学病理计算机科学物理细胞生物学免疫学
期刊介绍

Aims & Scope Recent Patents on Anti-Cancer Drug Discovery publishes review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

期刊ISSNprint: 1574-8928
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
2.52.83.0384.1692.612.1212.5092.956
历年发表/被引量
年份20252024202320222021202020192018201720162015201420132012
发表量2560586287453342394429273735
被引量50811751231120711201113934693656666662690631496
h-Index36
自引率4.00%
涉及的研究领域医学-药学
中科院2025年分区 ?
大类小类TOP期刊综述期刊
4区4区 肿瘤学
4区药学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
ONCOLOGYSCIEQ291/326
PHARMACOLOGY & PHARMACYSCIEQ179/352

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
ONCOLOGYSCIEQ2137/326
PHARMACOLOGY & PHARMACYSCIEQ2154/353
期刊主页http://www.recentpatentsonanticancerdrugdiscovery.com/https://benthamscience.com/journals/recent-patents-on-anti-cancer-drug-discovery
投稿网址http://bsp-cms.eurekaselect.com/index.php/PRA/login?source=%2Findex.php%2FPRA
出版商Bentham Science Publishers B.V.
出版国家(地区)U ARAB EMIRATES
出版语言English
出版周期Tri-annual
每年出版文章数40
Gold OA文章占比0.00%
原创研究文献占比
(排除综述)
41.18%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1574-8928%5BISSN%5D
平均审稿周期平均3.0个月
平均录用比例较易
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈